psychedelics as transformative therapeutics / Bryan L. Roth en The American Journal of Psychiatry, Año 2023 - Vol. 180 - No. 5 (Mayo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 5 (Mayo) . - pp. 340-347 Título : psychedelics as transformative therapeutics Tipo de documento: texto impreso Autores: Bryan L. Roth, Autor ; Ryan H. Gumpper, Autor Fecha de publicación: 2023 Artículo en la página: pp. 340-347 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Psicofarmacología, Farmacocinética, Psicodélicos, Drogas alucinógenas Resumen: Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems—mainly the serotonin 5-HT2A receptor. Link: ./index.php?lvl=notice_display&id=29984 [artículo] psychedelics as transformative therapeutics [texto impreso] / Bryan L. Roth, Autor ; Ryan H. Gumpper, Autor . - 2023 . - pp. 340-347. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 5 (Mayo) . - pp. 340-347 Palabras clave: Psicofarmacología, Farmacocinética, Psicodélicos, Drogas alucinógenas Resumen: Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems—mainly the serotonin 5-HT2A receptor. Link: ./index.php?lvl=notice_display&id=29984

---

1 (1 - 1 / 1)